Effectiveness of Secukinumab in the treatment of moderate-severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting
Articolo
Data di Pubblicazione:
2021
Citazione:
Effectiveness of Secukinumab in the treatment of moderate-severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting / S. Ribero, A. Ramondetta, G. Fabbrocini, V. Bettoli, C. Potenza, A. Chiricozzi, M. Licciardello, A.V. Marzano, L. Bianchi, G. Rozzo, L. Fania, C. Marasca, G. Odorici, A. Mambrin, C. Moltrasio, R.D. Caposiena Caro, N. Skroza, P. Quaglino, N. Siliquini, P. Dapavo. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - (2021). [Epub ahead of print] [10.1111/jdv.17178]
Abstract:
Hidradenitis suppurativa (HS) is a chronic inflammatory disease of the hair follicle. Albeit its pathogenesis is multifactorial, HS is regarded as mainly autoinflammatory in its origin. In particular, the high expression levels of interleukin (IL)-17A in the bloodstream and in lesional skin, of patients with HS, allows us to consider secukinumab as a potential drug capable of arresting the inflammatory cascade that characterizes this complicated pathology.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
HiSCR; IHS4; adalimumab; hidradenitis suppurativa; secukinumab
Elenco autori:
S. Ribero, A. Ramondetta, G. Fabbrocini, V. Bettoli, C. Potenza, A. Chiricozzi, M. Licciardello, A.V. Marzano, L. Bianchi, G. Rozzo, L. Fania, C. Marasca, G. Odorici, A. Mambrin, C. Moltrasio, R.D. Caposiena Caro, N. Skroza, P. Quaglino, N. Siliquini, P. Dapavo
Link alla scheda completa: